Literature DB >> 10866460

Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?

M G Guzmán1, G Kourí, S B Halstead.   

Abstract

During the Cuban dengue epidemics of 1981 and 1997, significant monthly increases were observed in the proportion of total cases that presented as dengue haemorrhagic fever or dengue shock syndrome (DHF/DSS), and in case-fatality rates for both dengue fever and DHF/DSS. We believe that theses increases can be explained by the hypothesis that some of the population of antibodies against dengue 1 virus raised after natural primary infections react with "neutralisation" determinants found on dengue 2 viruses. These heterotypic antibodies do not prevent secondary dengue 2 infections, but serve to down-regulate the disease to mild illness or symptomless infections. A population of dengue 2 viruses that replicates in dengue-1-immune hosts escape heterotypic neutralisation. When inoculated into a new dengue-1-immune host, these viruses are free to interact with the more abundant infection-enhancing antibodies to produce severe disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866460     DOI: 10.1016/S0140-6736(00)02303-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Public versus personal serotypes of a viral quasispecies.

Authors:  Lukas Hunziker; Adrian Ciurea; Mike Recher; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

2.  Characteristic of dengue disease in Taiwan: 2002-2007.

Authors:  Chien-Chou Lin; Yh-Hsiung Huang; Pei-Yun Shu; Ho-Sheng Wu; Yee-Shin Lin; Trai-Ming Yeh; Hsiao-Sheng Liu; Ching-Chuan Liu; Huan-Yao Lei
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 3.  Dengue: a continuing global threat.

Authors:  Maria G Guzman; Scott B Halstead; Harvey Artsob; Philippe Buchy; Jeremy Farrar; Duane J Gubler; Elizabeth Hunsperger; Axel Kroeger; Harold S Margolis; Eric Martínez; Michael B Nathan; Jose Luis Pelegrino; Cameron Simmons; Sutee Yoksan; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

4.  Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice.

Authors:  Lidice Bernardo; Adriana Yndart; Susana Vázquez; Luis Morier; María G Guzmán
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 5.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever.

Authors:  Yoshiro Nagao; Katia Koelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

Review 7.  Dengue--quo tu et quo vadis?

Authors:  Rubing Chen; Nikos Vasilakis
Journal:  Viruses       Date:  2011-09-01       Impact factor: 5.048

8.  Displacement of the predominant dengue virus from type 2 to type 1 with a subsequent genotype shift from IV to I in Surabaya, Indonesia 2008-2010.

Authors:  Atsushi Yamanaka; Kris C Mulyatno; Helen Susilowati; Eryk Hendrianto; Amor P Ginting; Dian D Sary; Fedik A Rantam; Soegeng Soegijanto; Eiji Konishi
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1.

Authors:  Hlaing Myat Thu; Kym Lowry; Thein Thein Myint; Than Nu Shwe; Aye Maung Han; Kyu Kyu Khin; Kyaw Zin Thant; Soe Thein; John Aaskov
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

10.  Biological and Molecular Properties of Dengue 2 Strains Isolated during the DHF/DSS Cuban Epidemic, 1981.

Authors:  Lester González; Mayling Alvarez; Delfina Del Rosario; Alequis Pavón; Irina Prado; Joel Díaz; Luis Morier; María G Guzmán
Journal:  Int J Biomed Sci       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.